Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
about
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.Biosafe nanoscale pharmaceutical adjuvant materialsHybrid nanoparticles for detection and treatment of cancerQuantum dots as a platform for nanoparticle drug delivery vehicle designRadiolabeled theranostics: magnetic and gold nanoparticlesDrug delivery nanoparticles in skin cancersNanoparticle Loaded Polymeric Microbubbles as Contrast Agents for Multimodal ImagingFunctionalization of a Triazine Dendrimer Presenting Four Maleimides on the Periphery and a DOTA Group at the Core.Quantum dot loaded immunomicelles for tumor imaging.Liposome encapsulation of thiol-capped CdTe quantum dots for enhancing the intracellular delivery.Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine.Hybrid Nanomaterial Complexes for Advanced Phage-guided Gene DeliveryNanoparticles for biomedical imagingInorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications.Uptake and intracellular fate of multifunctional nanoparticles: a comparison between lipoplexes and polyplexes via quantum dot mediated Förster resonance energy transferDesigning multifunctional quantum dots for bioimaging, detection, and drug deliveryRecent advances in nanoparticle-based Förster resonance energy transfer for biosensing, molecular imaging and drug release profilingEngineering nanomedicines for improved melanoma therapy: progress and promises.Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseasesAccelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease.Quantum dots - characterization, preparation and usage in biological systems.Applications for site-directed molecular imaging agents coupled with drug delivery potential.Quantum dot-based theranostics.Stimuli-responsive liposome-nanoparticle assemblies.Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging.Quantum dots in cancer therapy.Aptamers as imaging agents.Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics.Solid silica nanoparticles: applications in molecular imaging.Nanotechnology in the management of cervical cancer.Quantum dots: bright and versatile in vitro and in vivo fluorescence imaging biosensors.Design of multifunctional liposome-quantum dot hybrid nanocarriers and their biomedical application.Synthesis and Characterization of Mn:ZnSe/ZnS/ZnMnS Sandwiched QDs for Multimodal Imaging and Theranostic Applications.Quantiosomes as a multimodal nanocarrier for integrating bioimaging and Carboplatin delivery.Formulation design and evaluation of quantum dot-loaded nanostructured lipid carriers for integrating bioimaging and anticancer therapy.Development of nanoradiopharmaceuticals by labeling polymer nanoparticles with tc-99m.Cytotoxicity and cell imaging potentials of submicron color-tunable yttria particles.PEGylated liposome coated QDs/mesoporous silica core-shell nanoparticles for molecular imaging.Optical biosensors based on semiconductor nanostructuresTheranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.
P2860
Q26744835-56D1CA02-C523-43DC-A134-DC99301FB225Q26829798-D37A781B-8CB5-4354-9258-FD99293268B6Q26849404-06F2E49B-77F3-4455-8140-4E5C73688176Q26996556-6FA92DEA-A3B5-42D1-836D-8B9115837CA3Q28074696-84B00248-C842-4509-893E-0DEFB1D27796Q28390405-4A773D30-64F8-48FE-A37F-4CFE89B34983Q30370716-F8F565B4-7DC1-4370-92CB-3B1D86ADCD6DQ31058567-016289F6-A1D7-43D7-88FA-A67FEB555886Q33721349-5BE86888-AF7C-41C8-88F4-BB30BE4F2202Q33847994-A49DF036-91F4-4AE7-9CF5-E08689321CC4Q34033804-89F58773-99D0-4CE9-A8A7-529E1CBED9A7Q34459381-3A4DA5C3-6D30-495B-9A60-EBB116A622F7Q34989401-E5E7BDD6-17CB-4B4B-9552-DEF70180D95CQ35091821-3AB837D6-EDEB-4140-9F90-57219E4D67FDQ35255783-729651DE-E641-4C5F-9DF2-6F8DD702203BQ35538371-6AABA2B2-BEA5-4E90-A204-CE29CDBA4D61Q36538483-2E0BACCA-79B0-45DC-BA02-EFAADDE053E2Q36936646-E8AA8040-3A90-4CE5-9401-32B6B4022598Q37078082-F8A813D7-45DD-4AAD-B765-7DCB875E10D7Q37123107-B1194C7D-B7C0-4256-B2B1-FA6B73ED9FF4Q37427410-3CE35FFE-CD92-4BDE-8C36-65A6682230CEQ37529871-5656144C-981D-47F5-ABB3-EA507F9BB7E8Q37774587-DAEADE83-A919-48F8-8D5E-04A1A0D61643Q37887829-92565802-B2D1-414C-9283-EE6ED73728E5Q37957956-D82A6AAE-AA75-414D-A39C-7D2E3632A574Q37968640-B5EFAC1E-189A-4546-9DF0-DD37F28E15E5Q38089899-FA71C635-E2CA-45F4-ACEE-77DADA691DC7Q38127412-1747D98C-35BE-4963-AFB3-A80861B84B70Q38226377-BEB909E6-84CE-43AD-9D61-513619F011A4Q38370785-502A5140-AB55-4BCA-822D-1997191DF739Q38380533-9535139B-0DEF-4B3D-9F44-7997F582CBDBQ38691500-40B405CB-D269-4B33-8350-11585662CB63Q38811979-4EFADA75-9FCF-4B65-A00F-1766DB780F4AQ38987442-3F18B082-577E-42D4-A0EE-63F3EE76908CQ39199013-FC6C2538-89DA-4D5E-B7DE-B865CBDC82C3Q39364427-2093052A-F5B8-4899-85BC-2B023161247EQ39365073-A4E7F680-E63E-48F3-A92D-F1609D259F20Q39596265-C8519AC0-F84C-45FF-8D42-F5A1852F53DBQ40908633-FD9DB17E-B9F4-4EE3-BB66-139F6843255AQ41181847-0E79B844-475D-4255-A070-288F85214D0D
P2860
Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
@ast
Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
@en
type
label
Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
@ast
Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
@en
prefLabel
Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
@ast
Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
@en
P2093
P356
P1433
P1476
Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
@en
P2093
Khuloud T Al-Jamal
Paul H Bomans
Peter M Frederik
Wafa' T Al-Jamal
P304
P356
10.1002/SMLL.200701043
P577
2008-09-01T00:00:00Z